The IPO market generally performed well in September
The total number of new listings in September increased in comparison to the six initial public offerings (IPOs) in August, as there were ten new stocks listed on HKEX. As of September 30th, despite AUX ELECTRIC (2580.HK) seeing an 18% decrease in share price since listing, other IPOs all saw a rise in share prices. Among them, HIPINE (2583.HK) and 160 HEALTH (2656.HK) saw a 258% and 154% increase in share price, respectively, since listing.
Phillip Hong Kong Newly Listed Equities Index ETF (2835.HK)
The ETF aims to fully replicate the Solactive Hong Kong Newly Listed Equities Index, a rules-based equity benchmark designed to track the performance of securities that had a recent initial public offering or new listing on the main board of HKEX. The index is rebalanced quarterly, incorporating securities with IPOs or new listings within the last 756 business days, aiming for a total of 50 securities based on free-float market capitalization. The index also undergoes monthly IPO reviews to include recent IPOs, subject to liquidity and market capitalisation criteria.
September Monthly Review
Solactive HK Newly Listed Equities Index included BOSS ZHIPIN-W (2076.HK), SKB BIO-B (6990.HK), LAOPU GOLD (6181.HK), UNISOUND (9678.HK), INNOGEN-B (2591.HK), SF HOLDING (6936.HK), REPT BATTERO (666.HK), ZENERGY (3677.HK), SUNSHINE INS (6963.HK), and SUNSHINE PHARMA (6887.HK) in September through the quarterly rebalancing mechanism. And it also removed BEKE-W (2423.HK), MNSO (9896.HK), TRANSTHERA-B (2617.HK), MIRXES-B (2629.HK), STARPLUS LEGEND (6683.HK), TIANQI LITHIUM (9696.HK), SYNAGISTICS (2562.HK), CR BEVERAGE (2460.HK), TS LINES (2510.HK), WELLCELL HOLD (2477.HK), GUOFUHEE (2582.HK), LAEKNA-B (2105.HK), MICROPORT NEURO (2172.HK), RIMAG GROUP (2522.HK), TANWAN (9890.HK), YSB (9885.HK), HEALTHYWAY INC (2587.HK), GREEN TEA GROUP (6831.HK), VOICECOMM (2495.HK), DRINDA (2865.HK), and ETERNAL BEAUTY (6883.HK). The current number of constituent stocks has decreased from 61 to 50.
BOSS ZHIPIN-W (2076.HK) was first introduced and listed on HKEX in 2022, then it issued new shares for subscription in June 2025 and was therefore re-included in the Newly Listed Equities Index. The company pioneered the “direct recruitment model”, leveraging a mobile-native platform to innovatively integrate two-way communication and referrals into the online recruitment process, recreating the essence of a real-world recruitment scenario. The company was the first to adopt this model in China’s online recruitment industry. The development of this innovative business model, fundamentally different from existing models from the outset, has since transformed China’s online recruitment industry and user behaviour.
As of June 30th, 2025, the company’s half-year revenue in 2025 was 4.03 billion yuan (RMB, the same below), a year-on-year increase of 11.2%. Gross profit was 1.09 billion, an increase of 136.0% YoY; the gross profit margin rose from 12.8% in 2024 to 27.1% in 2025 for the same period. The increase in the company’s revenue and gross profit was mainly driven by the growth of paying enterprise customers and the reduction of expenses such as operating costs and marketing expenses.
Top 10 Holdings
This month, the Phillip Hong Kong Newly Listed Equities Index ETF’s top ten holdings changed. BEKE-W (2423.HK) fell out of the top ten holdings due to listing for over 3 years, while WUXI XDC (2268.HK) became the new top ten holding. The following industries are currently the focus of the index: industrials (including CATL, J&T EXPRESS-W, and UBTECH ROBOTICS), consumer discretionary (including LEAPMOTOR, MIDEA, and LAOPU GOLD), and information technology (including HORIZON ROBOT, INNOSCIENCE, and KINGSOFT CLOUD). The following figures show the top 10 holdings and sector breakdown of the Phillip HK Newly Listed Equities Index:

Key Components Update
Top constituent movers in September:

Bottom constituent movers in September:

The Phillip HK Newly Listed Index ETF (2835.HK) monthly performance for September
The Phillip HK Newly Listed Index ETF (2835.HK) recorded a 9.79% monthly increase in September, overperforming the Hang Seng Index’s (HSI) 7.09% monthly increase but underperforming the Hang Seng Tech Index’s (HSTI) 13.95% monthly increase. As of September 30th, this ETF had grown 48.18% since its listing, underperforming the HSI’s rose of 49.26% and the HSTI’s rose of 72.75%.

The following table compares the performance of the Phillip Hong Kong IPO Index ETF (2835.HK), the Hang Seng Index (HSI), and the Hang Seng Tech Index (HSTECH):

The IPO market generally performed well in August
The total number of listings in August continued to reduce in comparison to the ten initial public offerings (IPOs) in July, as there were six new stocks listed on HKEX. As of August 31st, despite SUNSHINE PHARMA (6887.HK) saw a 10% decrease in share price since listing, other IPOs all saw rise in share prices. Among them, AB&B BIO-TECH-B (2627.HK) and JIAXIN INTL RES (3858.HK) saw a 295% and 175% increase in share price, respectively, since listing.
Phillip Hong Kong Newly Listed Equities Index ETF (2835.HK)
The ETF aims to fully replicate the Solactive Hong Kong Newly Listed Equities Index, a rules-based equity benchmark designed to track the performance of securities that had a recent initial public offering or new listing on the main board of HKEX. The index is rebalanced quarterly, incorporating securities with IPOs or new listings within the last 756 business days, aiming for a total of 50 securities based on free-float market capitalization. The index also undergoes monthly IPO reviews to include recent IPOs, subject to liquidity and market capitalisation criteria.
August Monthly Review
Solactive HK Newly listed Equities Index included GEEKPLUS-W (2590.HK), HAITIAN FLAV (3288.HK), LEADS BIOLABS-B (9887.HK), and LENS (6613.HK) in August through the fast-track mechanism. The current number of constituent stocks has increased from 57 to 61.
GEEKPLUS-W (2590.HK) is a leader in the global autonomous mobile robot (“AMR”) market. The company offers a series of AMR solutions to empower warehouse fulfilment and industrial material transport, enhancing supply chain efficiency while reducing reliance on manual labour. According to data, as of December 31st, 2024, the company has shipped approximately 56,000 AMRs across over 40 countries and regions worldwide. In 2024, it occupied a 9.0% market share in the overall global warehouse fulfilment AMR solution market and approximately 1% market share of the global warehouse automation solution market.
As of December 31st, 2024, the company’s revenue in 2024 was 2.41 billion yuan (RMB, the same below), a year-on-year increase of 12.4%. Gross profit was 837.17 million, an increase of 27.0% YoY; the gross profit margin rose from 30.8% in 2023 to 34.8% in 2024. The company’s revenue growth stems from an increase in the number of customers and an increase in average revenue per customer, which led to increased sales of the company’s warehouse fulfilment AMR solutions. Furthermore, the company’s gross margin in 2024 also increased due to a steady decline in costs, driven by continued cost reductions through product design optimization and supply chain sourcing.
Top 10 Holdings
This month, the Solactive Hong Kong Newly Listed Equities Index’s top ten holdings changed. DUALITYBIO-B (9606.HK) and MIXUE GROUP (2097.HK) fell out of the top ten holdings due to price fluctuations, while INNOSCIENCE (2577.HK) and XTALPI (2228.HK) became the new top ten holdings. The following industries are currently the focus of the index: industrials (including J&T EXPRESS-W, CATL, and TUHU-W), information technology (including HORIZON ROBOT, INNOSCIENCE, and KINGSOFT CLOUD), and consumer discretionary (including MIDEA, LEAPMOTOR, and MIXUE GROUP). The following figures show the top 10 holdings and sector breakdown of the Phillip HK Newly Listed Equities Index:

Key Components Update
Top constituent movers in August:

Bottom constituent movers in August:

The Phillip HK Newly Listed Index ETF (2835.HK) monthly performance for August
The Phillip HK Newly Listed Index ETF (2835.HK) recorded a 10.26% monthly increase in August, overperforming the Hang Seng Index’s (HSI) 1.23% monthly increase and the Hang Seng Tech Index’s (HSTI) 4.06% monthly increase. As of August 31st, this ETF had grown 34.96% since its listing, underperforming the HSI’s rose of 39.38% and the HSTI’s rose of 51.61%.

The following table compares the performance of the Phillip Hong Kong IPO Index ETF (2835.HK), the Hang Seng Index (HSI), and the Hang Seng Tech Index (HSTECH):

The IPO market showed a trend of differentiation in July
The total number of listings in July slightly reduced in comparison to the fifteen initial public offerings (IPOs) in June, but there were still ten new stocks listed on HKEX, and the overall performance of the IPO market was divided. As of July 31st, LEADS BIOLABS-B (9887.HK) and FORTIOR (1304.HK) saw a 106% and 26% increase in share price, respectively, since listing. Whereas CLOUDBREAK-B (2592.HK) and DAZHONG DENTAL (2651.HK) saw a 47% and 28% decrease in share price since listing, respectively.
Phillip Hong Kong Newly Listed Equities Index ETF (2835.HK)
The ETF aims to fully replicate the Solactive Hong Kong Newly Listed Equities Index, a rules-based equity benchmark designed to track the performance of securities that had a recent initial public offering or new listing on the main board of HKEX. The index is rebalanced quarterly, incorporating securities with IPOs or new listings within the last 756 business days, aiming for a total of 50 securities based on free-float market capitalization. The index also undergoes monthly IPO reviews to include recent IPOs, subject to liquidity and market capitalisation criteria.
July Monthly Review
Solactive HK newly listed Equities Index included HENGRUI PHARMA (1276.HK), SANHUA (2050.HK), TRANSTHERA-B (2617.HK), MIRXES-B (2629.HK), CAOCAO INC (2643.HK), ETERNAL BEAUTY (6883.HK), GREEN TEA GROUP (6831.HK), and DRINDA (2865.HK) in July through the fast-track mechanism. And it also removed ZENERGY (3677.HK). The current number of constituent stocks has increased from 50 to 57.
HENGRUI PHARMA (1276.HK) is a leading innovative global pharmaceutical company rooted in China. The company strategically focus on comprehensive therapeutic areas with significant unmet medical needs and growth potential. These mainly include oncology, metabolic and cardiovascular diseases, immunological and respiratory diseases, and neuroscience. According to data, the aggregate global pharmaceutical market corresponding to the company’s major therapeutic areas in 2023 was US$845.8 billion, accounting for 57.4% of the overall global pharmaceutical market for the same year; and it is expected to grow at a CAGR of 6.4% from 2023 to 2028, surpassing the CAGR of 5.7% for the overall global pharmaceutical market growth during the same period.
As of December 31st, 2024, the company’s revenue in 2024 was 279.85 billion yuan (RMB, the same below), a year-on-year decrease of 22.6%. Gross profit was 241.36 billion, an increase of 25.1% YoY; the gross profit margin rose from 84.6% in 2023 to 86.2% in 2024. The profit for the year attributable to the company’s equity holders was 63.37 billion, an increase of 47.3% YoY. The company’s revenue growth this year mainly benefited from its expansion in the global and Chinese pharmaceutical markets and growth in major therapeutic areas, continuous development and commercialization of new drugs and product portfolio strengthening, effective control of costs and expenses, entry into medical insurance plans and participation in drug procurement competition in China’s public medical institutions.
Top 10 Holdings
This month, the Solactive Hong Kong Newly Listed Equities Index’s top ten holdings changed. DOBOT (2432.HK) fell out of the top ten holdings due to market fluctuations, while DUALITYBIO-B (9606.HK) became the new top ten holdings. The following industries are currently the focus of the index: industrials (including J&T EXPRESS-W, CATL, and DOBOT), consumer discretionary (including MIDEA, LEAPMOTOR, and MIXUE GROUP), and information technology (including HORIZON ROBOT, KINGSOFT CLOUD, and INNOSCIENCE). The following figures show the top 10 holdings and sector breakdown of the Phillip HK Newly Listed Equities Index:

Key Components Update
Top constituent movers in July:

Bottom constituent movers in July:

The Phillip HK Newly Listed Index ETF (2835.HK) monthly performance for July
The Phillip HK Newly Listed Index ETF (2835.HK) recorded a 7.31% monthly increase in July, overperforming the Hang Seng Index’s (HSI) 2.91% monthly increase and the Hang Seng Tech Index’s (HSTI) 3.54% monthly increase. As of July 31st, this ETF had grown 22.40% since its listing, underperforming the HSI’s rose of 37.69% and the HSTI’s rose of 45.70%.

The IPO market was hot in June
The total number of listings in June kept rising in comparison to the ten initial public offerings (IPOs) in May. This month, fifteen new stocks were listed on HKEX, and the overall IPO market was performing well. As of June 30th, TRANSTHERA-B (2617.HK) and ZHOU LIU FU (6168.HK) saw a 129% and 102% increase in share price, respectively, since listing. Whereas METALIGHT (2605.HK) and ETERNAL BEAUTY (6883.HK) saw a 37% and 29% decrease in share price since listing, respectively.
Phillip Hong Kong Newly Listed Equities Index ETF (2835.HK)
The ETF aims to fully replicate the Solactive Hong Kong Newly Listed Equities Index, a rules-based equity benchmark designed to track the performance of securities that had a recent initial public offering or new listing on the main board of HKEX. The index is rebalanced quarterly, incorporating securities with IPOs or new listings within the last 756 business days, aiming for a total of 50 securities based on free-float market capitalization. The index also undergoes monthly IPO reviews to include recent IPOs, subject to liquidity and market capitalisation criteria.
June Monthly Review
Solactive HK Newly listed Equities Index included CATL (3750.HK), DUALITYBIO-B (9606.HK), ZENERGY (3677.HK), BEAUTYFARM MED (2373.HK), TS LINES (2510.HK), WELLCELL HOLD (2477.HK), STARPLUS LEGEND (6683.HK), RIMAG GROUP (2522.HK), and VOICECOMM (2495.HK) in June through the quarterly rebalancing mechanism. And it also removed NIO-SW (9866.HK), LEPU BIO-B (2157.HK), SUPER HI (9658.HK), FENBI (2469.HK), MINIEYE (2431.HK), AUTOSTREETS (2443.HK), HUITONGDA NET (9878.HK), and IMOTIONTECH (1274.HK). The current number of constituent stocks has increased from 49 to 50.
CATL (3750.HK) is a globally leading innovative new energy technology company, which is primarily engaged in the research, development, production, and sales of EV batteries and ESS batteries. The company promotes the transition from mobile and stationary fossil energy sources to sustainable alternatives, as well as creating integrated innovative solutions for new applications through advancements in electrification and intelligent technologies. As of December 31st, 2024, the company’s EV batteries were installed in over 17 million vehicles, and its ESS batteries were deployed in over 1,700 projects across the globe, representing the broadest coverage of customer and end-user base globally.
As of December 31st, 2024, the company’s revenue in 2024 was 362.01 billion yuan (RMB, the same below), a year-on-year decrease of 9.7%. Gross profit was 88.49 billion, an increase of 15.0% YoY; the gross profit margin rose from 19.2% in 2023 to 24.4% in 2024. The profit for the year attributable to the company’s equity holders was 52.03 billion, an increase of 16.4% YoY. This year, the company’s revenue decreased, but profits continued to grow, mainly benefiting from the advantages of innovative products. Although the average sales price of battery systems has been reduced due to the decline in prices of raw materials such as lithium carbonate, the unit profitability of the company’s battery systems remained stable despite the decline in the average sales price, thereby driving an increase in gross profit margin.
Top 10 Holdings
This month, the Solactive Hong Kong Newly Listed Equities Index’s top ten holdings changed. Among the top ten holdings in May, NIO-SW (9866.HK) was removed from the quarterly rebalancing because it has been listed for more than three years, WL DELICIOUS (9985.HK) and HEALTHYWAY INC (2587.HK) also fell out of the top ten holdings due to market fluctuations, while CATL (3750.HK), MIXUE GROUP (2097.HK), and DOBOT (2432.HK) became the new top ten holdings. The following industries are currently the focus of the index: consumer discretionary (including MIDEA, LEAPMOTOR, and MIXUE GROUP), industrials (including CATL, J&T EXPRESS-W, and DOBOT), and information technology (including HORIZON ROBOT, KINGSOFT CLOUD, and FOURTH PARADIGM). The following figures show the top 10 holdings and sector breakdown of the Phillip HK Newly Listed Equities Index:

Key Components Update
Top constituent movers in June:

Bottom constituent movers in June:

The Phillip HK Newly Listed Index ETF (2835.HK) monthly performance for June
The Phillip HK Newly Listed Index ETF (2835.HK) recorded a 1.15% monthly increase in June, underperforming the Hang Seng Index’s (HSI) 3.36% monthly increase and the Hang Seng Tech Index’s (HSTI) 2.56% monthly increase. As of June 30th, this ETF had grown 14.07% since its listing, underperforming the HSI’s rise of 33.79% and the HSTI’s rise of 41.68%.

The IPO market was hot in May
The total number of listings in May rose significantly in comparison to the two initial public offerings (IPOs) in April. This month, ten new stocks were listed on HKEX, and the overall IPO market was performing well. As of May 31st, BRETON (1333.HK) and HENGRUI PHARMA (1276.HK) saw a 71% and 32% increase in share price, respectively, since listing. Whereas PEGBIO CO-B (2565.HK) and SHOUHUI GROUP (2621.HK) saw a 35% and 18% decrease in share price since listing, respectively.
Phillip Hong Kong Newly Listed Equities Index ETF (2835.HK)
The ETF aims to fully replicate the Solactive Hong Kong Newly Listed Equities Index, a rules-based equity benchmark designed to track the performance of securities that had a recent initial public offering or new listing on the main board of HKEX. The index is rebalanced quarterly, incorporating securities with IPOs or new listings within the last 756 business days, aiming for a total of 50 securities based on free-float market capitalization. The index also undergoes monthly IPO reviews to include recent IPOs, subject to liquidity and market capitalisation criteria.
May Monthly Review
In May, the Solactive Hong Kong IPO Index included MIXUE GROUP (2097.HK) through the fast-track mechanism and removed LAOPU GOLD (6181.HK), VISEN PHARMA-B (2561.HK), and AIM VACCINE (6660.HK). The current number of constituent stocks has decreased from 51 to 49.
MIXUE GROUP (2097.HK) is a leading freshly-made drinks company and is committed to providing value-for-money products to consumers, including freshly-made fruit drinks, tea drinks, ice cream and coffee, typically priced around approximately 6 RMB per item. Through a franchise model, the company has cultivated a network of over 45,000 stores spanning China and 11 overseas countries as of September 30th, 2024. The company is the largest freshly-made drinks company both in China and worldwide in terms of the number of stores, according to data.
As of December 31st, 2023, the company’s revenue in 2023 was 20,302 million yuan (RMB, the same below), a year-on-year increase of 49.6%. Gross profit was 5,999 million, an increase of 55.9% YoY; the gross profit margin rose from 28.3% in 2022 to 29.5% in 2023. The profit for the year attributable to the company’s equity holders was 3,137 million, an increase of 57.1% YoY. Factors such as the increase in consumer demand for freshly made beverages, the expansion of the store network, the ability to manage the store network, scaling and efficient supply chain capabilities have directly driven the company’s sustainable growth in revenue and profits.
Top 10 Holdings
This month, the Solactive Hong Kong Newly Listed Equities Index’s top ten holdings changed. LAOPU GOLD (6181.HK) was removed from the index, while HEALTHYWAY INC (2587.HK) became the new top ten holdings of the month. The following industries are currently the focus of the index: consumer discretionary (including MIDEA, NIO, and LEAPMOTOR), information technology (including HORIZON ROBOT, KINGSOFT CLOUD, and ROBOSENSE), and consumer staples (including GIANT BIOGENE, WL DELICIOUS, and MAO GEPING). The following figures show the top 10 holdings and sector breakdown of the Phillip HK Newly Listed Equities Index:

Key Components Update
Top constituent movers in May:

Bottom constituent movers in May:

The Phillip HK Newly Listed Index ETF (2835.HK) monthly performance for May
The Phillip HK Newly Listed Index ETF (2835.HK) recorded a 0.41% monthly decrease in May, underperforming the Hang Seng Index’s (HSI) 5.29% monthly increase and the Hang Seng Tech Index’s (HSTI) 1.63% monthly increase. As of May 31st, this ETF had grown 12.77% since its listing, underperforming the HSI’s rise of 29.44% and the HSTI’s rise of 38.15%.

The IPO market did not perform well in April
The total number of listings in April dropped significantly in comparison to the six initial public offerings (IPOs) in March. This month, only two new stocks were listed on HKEX, but the overall IPO market was performing well. As of April 30th, DUALITYBIO-B (9606.HK) and ZENERGY (3677.HK) saw a 119% and 1% increase in share price, respectively, since listing.
Phillip Hong Kong Newly Listed Equities Index ETF (2835.HK)
The ETF aims to fully replicate the Solactive Hong Kong Newly Listed Equities Index, a rules-based equity benchmark designed to track the performance of securities that had a recent initial public offering or new listing on the main board of HKEX. The index is rebalanced quarterly, incorporating securities with IPOs or new listings within the last 756 business days, aiming for a total of 50 securities based on free-float market capitalization. The index also undergoes monthly IPO reviews to include recent IPOs, subject to liquidity and market capitalisation criteria.
April Monthly Review
In April, the Solactive Hong Kong IPO Index included CHIFENG GOLD (6693.HK) and VISEN PHARMA-B (2561.HK) through the fast-track mechanism and removed WELLCELL HOLD (2477.HK). The current number of constituent stocks has increased from 50 to 51.
CHIFENG GOLD (6693.HK) is principally engaged in the mining, processing, and sale of gold. The company owned and operated seven gold and polymetallic mines across the world, including China, Southeast Asia, and West Africa. According to the report, the company experienced the fastest growth among major gold producers in China from 2021 to 2023, with a CAGR of 33.1% in gold production over that period. Also, the company had the greatest overseas presence in terms of both overseas assets and revenue contribution among gold producers in China as of the end of the year 2023.
As of December 31st, 2023, the company’s revenue in 2023 was 7,221.0 million yuan (RMB, the same below), a year-on-year increase of 15.2%. Gross loss was 2,352.9 million, an increase of 31.1% YoY; the gross loss margin rose from 28.6% in 2022 to 32.6% in 2023. The profit for the year attributable to the company’s equity holders was 804.5 million, an increase of 78.4% YoY. The increase in the company’s revenue is directly related to the increase in the gold and non-ferrous metal prices and demand in end markets, the increase in production through the acquisition of new mining areas, the decrease in sales costs and increase in recovery rates, and the exchange rate fluctuations.
Top 10 Holdings
This month, the Solactive Hong Kong Newly Listed Equities Index’s top ten holdings changed. DOBOT (2432.HK) fell out of the top ten holdings due to market movement, while WL DELICIOUS (9985.HK) became the new top ten holdings of the month. The following industries are currently the focus of the index: consumer discretionary (including NIO, MIDEA, and LEAPMOTOR), information technology (including HORIZON ROBOT, KINGSOFT CLOUD, and ROBOSENSE), and consumer staples (including WL DELICIOUS, GIANT BIOGENE, and MAO GEPING). The following figures show the top 10 holdings and sector breakdown of the Phillip HK Newly Listed Equities Index:

Key Components Update
Top constituent movers in April:

Bottom constituent movers in April:

The Phillip HK Newly Listed Index ETF (2835.HK) monthly performance for April
The Phillip HK Newly Listed Index ETF (2835.HK) recorded a 0.95% monthly increase in April, outperforming the Hang Seng Index’s (HSI) 4.33% monthly decrease and the Hang Seng Tech Index’s (HSTI) 5.70% monthly decrease. As of April 30th, this ETF had grown 13.23% since its listing, underperforming the HSI’s rise of 22.94% and the HSTI’s rise of 35.93%.